Renal Transplant Rejection: Clinical Trials

7 trials for Renal Transplant Rejection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 7 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Active not recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 14Active not recruiting 1, Completed 1, Recruiting 1, Withdrawn 1

Follow Renal Transplant Rejection: new trials by email Literature Review of Renal Transplant Rejection trials Research Report on Renal Transplant Rejection

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation
Tacrolimus - Renal Transplant Rejection, Renal Transplant Infection
Phase 1 / Phase 2WithdrawnUniversity College, London2023-02-202023-05-11
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Donor CD34+ and CD3+ cells - Renal Transplant Rejection, Tolerance
Phase 1 / Phase 2RecruitingJeffrey Veale, MD152019-11-062026-05-08
Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
Fostamatinib - Renal Transplant Rejection
Phase 1 / Phase 2Active not recruitingImperial College London82019-05-082024-11-25
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
Sonazoid, contrast enhanced ultrasonography - Renal Transplant Rejection
Phase 2CompletedBrigham and Women's Hospital82018-05-302023-03-06
Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)
Antithymocyte Immunoglobulin (Rabbit) - Renal Transplant Rejection
Phase 2CompletedProf. Dr. Petra Reinke682016-12-152021-01-29
Belimumab Impacting Transplant Eligibility
belimumab, Bortezomib, Rituximab - Renal Transplant Rejection
Phase 1 / Phase 2CompletedE. Steve Woodle112015-06-012019-04-22
Mesenchymal Stromal Cell Therapy in Renal Recipients
Mesenchymal Stromal Cells - Renal Transplant Rejection, Fibrosis
Phase 2UnknownLeiden University Medical Center702014-03-012020-09-17

Narrower conditions

Fibrosis (1)

Broader conditions

Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Tacrolimus (2)  ·  Antilymphocyte Serum (1)  ·  Bortezomib (1)  ·  Infliximab (1)  ·  Mycophenolic Acid (1)  ·  Plasmapheresis (1)  ·  Prednisolone (1)  ·  Rituximab (1)  ·  Sonazoid (1)  ·  belimumab (1)  ·  fostamatinib (1)

Sponsors

Brigham and Women's Hospital (1)  ·  E. Steve Woodle (1)  ·  Imperial College London (1)  ·  Jeffrey Veale, MD (1)  ·  Leiden University Medical Center (1)  ·  Prof. Dr. Petra Reinke (1)  ·  University College, London (1)

Countries

United States (3)  ·  Germany (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

E. Steve Woodle, MD (1)  ·  Frederick Tam, MBBChir (1)  ·  Jeffrey Veale, MD (1)  ·  Marlies EJ Reinders, MD/PhD (1)  ·  Ondrej Viklicky, PhD, MD (1)  ·  Reinke Reinke, PhD, MD (1)  ·  Reza Abdi, MD (1)

Results publications

PMID 23349326, PMID 25491391, PMID 31335773, PMID 37426430, PMID 37525369, PMID 40374867

NIH funding

2018 (1)